Feb 22, 2019 - Galapagos NV (NASDAQ:GLPG) Q4 2018 Earnings Conference Call February 22, 2019 08:00 AM ET Company Participants Elizabeth Goodwin - Investor Relations Onno van de Stolpe - Chief Executive Officer Bart
Feb 25, 2019 - PostNL NV (OTCPK:PNLYY) Q4 2018 Earnings Conference Call February 25, 2019, 05:00 ET Company Participants Hendrika Verhagen - Chairman & CEO Jochem van de Laarschot - Director Communications &
Feb 25, 2019 - OFIX earnings call for the period ending December 31, 2018.
Feb 28, 2019 - Anheuser-Busch InBev SA/NV (NYSE:BUD) Q4 2018 Earnings Conference Call February 28, 2019 9:00 a.m. ET Company Participants Carlos Brito - CEO Felipe Dutra - Chief Financial and Solutions Officer Confe
Mar 01, 2019 - Playa Hotels & Resorts NV (NASDAQ:PLYA) Q4 2018 Earnings Conference Call March 01, 2019 9:00 AM ET Company Participants Ryan Hymel - Executive Vice President & Chief Financial Officer Bruce Wa
Mar 06, 2019 - Ligand Pharmaceuticals (LGND) announces sale of all rights to Novartis' Promacta, including royalty payments on global sales, to Royalty Pharma.
Mar 08, 2019 - Gilead (GILD) presents encouraging data on two leading HIV regimens, Bikatrvy and Descovy.
Mar 12, 2019 - Roche (RHHBY) gets FDA approval for immuno-oncology drug, Tecentriq in combination with Abraxane for the treatment of breast cancer.
Mar 14, 2019 - Roche (RHHBY) gets approval from European Commission for a label expansion of hemophilia drug, Hemlibra.
Mar 19, 2019 - Two medical-device makers and one big drugmaker are on a roll. But can their momentum continue?